LeMaitre Vascular (LMAT) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
The $19.2 million purchase of B. Braun vascular products comes with an 18-to-24-month handoff, and the CEO is betting a no-backorder promise wins customers back.
Earnings
The vascular device maker's third-quarter sales rose 11% to $68.0 million, while reported EPS fell 14% against a year-earlier tax credit.
SEC Filings
An 8-K says Roberts will leave his employee role and the presidency at year-end while remaining a director through a term ending in 2029.